Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sacha Obaid

Plastic Surgery Southlake, TX Medical Doctor

NPI 1295941169 CMS profile 13644

1545 E Southlake Blvd, Suite 250, Southlake, TX 76092

Open in the dashboard

General payments

$14,906

151 records reported · program years 2019–2025

Research payments

$3,500

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sacha Obaid of Southlake, TX is reported in the CMS Open Payments database as having received $14,906 across 151 general payments and $3,500 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,106 13
2024 General $779 25
2023 General $1,152 22
2022 General $638 16
2021 General $9,370 37
2021 Research $3,500 1
2020 General $595 14
2019 General $1,266 24

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sacha Obaid
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Sacha Obaid were reported at $1,106. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Sacha Obaid Plastic Surgery median Middle half National median
2019 $1,266 $371 $122–$1,483 $163
2020 $595 $158 $52–$438 $114
2021 $9,370 $249 $87–$752 $132
2022 $638 $274 $102–$793 $149
2023 $1,152 $299 $113–$891 $160
2024 $779 $361 $124–$1,062 $164
2025 $1,106 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Allergan Inc. $9,329 56 payments
  2. Sientra, Inc. $2,078 26 payments
  3. AbbVie, Inc. $1,113 44 payments
  4. Integra LifeSciences Corporation $988 7 payments
  5. Merz North America, Inc. $701 5 payments
  6. Galderma Laboratories, L.P. $273 5 payments
  7. Davol Inc. $158 2 payments
  8. Motiva USA, LLC $119 1 payment
  9. Tepha Inc $53 2 payments
  10. Mentor Worldwide LLC $41 1 payment
  11. Other $54 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $8,461 4 payments
  2. Food and Beverage $5,600 145 payments
  3. Long term medical supply or device loan $845 2 payments
Products named General payments · program years 2019–2025
  1. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $2,078 26 payments
  2. DuraSorb Monofilament Mesh $845 2 payments
  3. BOTOX $769 40 payments
  4. Xeomin $701 5 payments
  5. NATRELLE SALINE-FILLED BREAST IMPLANTS $488 14 payments
  6. NATRELLE $211 6 payments
  7. Agento I.C. Silver-Coated Endotracheal Tube $158 2 payments
  8. SURGIMEND $142 5 payments
  9. Integra $142 5 payments
  10. OMNIGRAFT $142 5 payments
  11. Other $701 31 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Sientra, Inc. $3,500 1 payment

Records

152 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record